CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $6,669,998
- in 2 filings, $6.7M under 10b5-1 plans
Net +$28,353,034. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −200 | $259.13 | $52K | 3,272 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −841 | $262.18 | $220K | 2,431 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −143 | $263.08 | $38K | 2,288 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −116 | $264.73 | $31K | 2,172 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −700 | $265.36 | $186K | 1,472 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −274 | $266.91 | $73K | 1,198 |
| 2024-04-01 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 10,000 | ||
| 2024-04-01 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 0 | ||
| 2024-04-01 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,277 | 11,212 | ||
| 2023-06-15 | BATE KENNETH Director | Grant or award | +1,198 | 1,198 | ||
| 2022-06-16 | BATE KENNETH Director | Grant or award · Stock Option (Right to Buy) | +9,470 | 9,470 | ||
| 2021-06-17 | BATE KENNETH Director | Grant or award · Stock Option (Right to Buy) | +12,489 | 12,489 | ||
| 2020-06-17 | BATE KENNETH Director | Grant or award · Stock Option (Right to Buy) | +6,000 | 6,000 | ||
| 2019-06-27 | BATE KENNETH Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2018-06-19 | BATE KENNETH Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2017-06-29 | BATE KENNETH Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2016-07-22 | BATE KENNETH Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2016-07-22 | BATE KENNETH Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 |
Page 4 of 4 · 78 trades